B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Tandutinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tandutinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

quizartinib
28 shared targets
defosbarasertib
26 shared targets
linifanib
32 shared targets
bms
14 shared targets
brivanib
17 shared targets
cediranib
26 shared targets
pexidartinib
10 shared targets
enmd
13 shared targets
pha
36 shared targets
osi
16 shared targets
Loading evidence profile...

This evidence profile for Tandutinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.